Skip to main content
. 2020 May 28;54(2):209–220. doi: 10.2478/raon-2020-0026

Table 1.

Patient characteristics

IIIA (N = 321) IIIB (N = 262) IIIA + IIIB (N = 583)
Characteristic
P *
N (%) N (%) N (%)
Age
    < 65 years 155 (48.3) 117 (44.7) 272 (46.7)
    ≥ 65 years 166 (51.7) 145 (55.3) 311 (53.3)
    Mean ± SD (years) 64.8 ± 10.5 65.1 ± 10.1 64.9 ± 10.3 0.429
    Median (years) 65.4 66.0 65.6
Gender
    Female 92 (28.7) 96 (37.0) 188 (32.2)
    Male 229 (71.3) 166 (63.6) 395 (67.8) 0.050
Smoking status
    Current smoker 161 (50.2) 147 (56.3) 308 (52.8)
    Former smoker 127 (39.6) 92 (35.2) 219 (37.6)
    Never smoker 26 (8.1) 16 (6.1) 42 (7.2)
    Unknown 7 (2.2) 7 (2.7) 14 (2.4) 0.446
Weight loss ≥10% within prior three months
    No 243 (75.7) 163 (62.5) 406 (69.6)
    Yes 50 (15.6) 70 (26.8) 120 (20.6)
    Unknown 28 (8.7) 29 (11.0) 57 (9.8) <0.001
WHO performance status
    0 86 (26.8) 60 (23.0) 146 (25.0)
    1 194 (60.4) 144 (54.9) 338 (58.0)
    2 31 (9.7) 41 (15.7) 72 (12.3)
    3 10 (3.1) 17 (6.5) 27 (4.6) 0.025
Histology
    Squamous cell carcinoma 176 (54.8) 133 (51.0) 309 (53.0)
    Adenocarcinoma 115 (35.8) 105 (40.0) 220 (37.7)
    NSCLC NOS 18 (5.6) 18 (6.9) 36 (6.2)
    Other 12 (3.7) 6 (2.3) 18 (3.1) 0.477

* = Chi-square test for IIIA vs. IIIB; NOS = not otherwise specified; NSCLC = non-small-cell lung cancer; SD = standard deviation